Nature Research, Nature Medicine, 3(13), p. 279-280, 2007
DOI: 10.1038/nm0307-279
Full text: Download
New classes of chemical compounds along with more efficient methods to identify drug targets have produced exciting developments in antituberculous antibiotics. Will the new drugs now entering clinical trials have an impact on treatment?